US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist

67.610
-0.750-1.10%

Close Mar 28 16:00 ET

67.610
0.0000.00%

Post 19:17 ET

1.47BMarket Cap-65.01P/E (TTM)

ANI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ANI Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 28, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	175.35M	190.57M	+15.22M
Beat Est.	+33.19%	+44.75%	+8.68%
EPS	0.29	-0.55	-0.84
Miss Est.	+633.25%	-2850.00%	-287.52%

Analyst Rating

Strong Buy

Mar 14, 2025

ANI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 188.553M	--
--	2025/Q1	-- / 179.751M	--
Feb 28, 2025	2024/Q4	190.574M / 175.355M	--
Nov 8, 2024	2024/Q3	148.332M / 144.375M	--
Aug 6, 2024	2024/Q2	138.040M / 129.053M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 188.553M--

--2025/Q1-- / 179.751M--

Feb 28, 20252024/Q4190.574M / 175.355M--

Nov 8, 20242024/Q3148.332M / 144.375M--

Aug 6, 20242024/Q2138.040M / 129.053M--

Unlock Free Earnings Estimates

Open Account

ANI Pharmaceuticals Earnings Reports

ANI Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 28 07:06 ET

ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

Feb 28 06:55 ET

ANI Pharmaceuticals | 8-K: ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

Jan 13 07:29 ET

ANI Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 08:05 ET